Anzup Cancer Trials Group Limited
About
Anzup Cancer Trials Group Limited is a multidisciplinary cancer cooperative trials group dedicated to improving the lives of individuals affected by 'below the belt' cancers, including bladder, kidney, testicular, penile, and prostate cancers. They achieve this by conducting high-quality, practice-changing multidisciplinary collaborative clinical trials in Australia and New Zealand.
Tips for Applicants
Applicants for ANZUP's research grants, particularly the Below the Belt Research Fund, should focus on investigator-initiated studies that address critical clinical questions in urogenital cancers. Proposals should highlight innovative ideas with the potential to impact patient outcomes, including quality of life and reduced side effects. Emphasize how the research fills gaps where traditional government or industry funding might not be available.
Giving Philosophy
ANZUP's philosophy centers on improving outcomes for people with urogenital cancers by generating evidence through clinical trials. They actively identify critical areas of unmet need, collaborate with leading clinicians, scientists, and consumers, and prioritize research that leads to better treatments, improved quality of life, and reduced side effects for patients. They also foster new research ideas through seed funding and aim for independence from external grant uncertainties.
Notable Grants
ACNC Financial History
| Year | Grants Given | Revenue | Total Assets | Net Assets |
|---|---|---|---|---|
| FY2023 | $3.7M | $7.5M | $18.2M | $9.0M |
| FY2022 | $4.9M | $8.6M | $16.8M | $8.2M |
| FY2021 | $2.6M | $5.1M | $14.0M | $7.4M |
| FY2020 | $2.1M | $4.8M | $11.9M | $6.8M |
| FY2019 | $1.7M | $5.3M | $8.5M | $4.9M |
| FY2018 | $2.2M | $4.2M | $6.3M | $4.0M |
| FY2017 | $1.4M | $3.7M | $5.4M | $3.8M |
| 7yr total | $18.7M | Source: ACNC Annual Information Statements | ||
Programs (from website)
Below the Belt Research Fund Grant 2025
This fund provides seed funding to ANZUP members for investigator-initiated studies that explore and test innovative ideas in urogenital cancer research, particularly where government or industry funding is not available.